Weber Christophe Pierre has filed 8 insider transactions across 2 companies since March 2026.
Most recent transaction: a grant/award of 2660 shares of BOSTON SCIENTIFIC CORP ($BSX) on May 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Weber Christophe Pierre | Director | A | Deferred Stock Units | 2660 | $0.00 | 2,660.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| May 7, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Weber Christophe Pierre | Director | A | Common Stock | 1140 | $0.00 | 3,786.0000 | 1,494,500,000 | 43.08% | 0.00% |
| May 7, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Weber Christophe Pierre | Director | A | Common Stock | 1767 | $0.00 | 2,646.0000 | 1,494,500,000 | 201.02% | 0.00% |
| April 27, 2026 | TAKEDA PHARMACEUTICAL CO LTD | $TAK | Weber Christophe Pierre | President and CEO | A | Tax Obligation Award | 78978 | $0.00 | 125,345.0000 | 1,557,765,596 | 170.33% | 0.01% |
| April 27, 2026 | TAKEDA PHARMACEUTICAL CO LTD | $TAK | Weber Christophe Pierre | President and CEO | A | Ordinary Shares | 78900 | $0.00 | 1,014,200.0000 | 1,557,765,596 | 8.44% | 0.01% |
| April 27, 2026 | TAKEDA PHARMACEUTICAL CO LTD | $TAK | Weber Christophe Pierre | President and CEO | A | American Depositary Shares | 165370 | $0.00 | 418,803.0000 | 1,557,765,596 | 65.25% | 0.01% |
| March 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Weber Christophe Pierre | Director | A | Common Stock | 556 | $0.00 | 556.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| March 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Weber Christophe Pierre | Director | A | Common Stock | 323 | $0.00 | 879.0000 | 1,494,500,000 | 58.09% | 0.00% |